Food Noise: The Voice Telling You to Eat (Guide)
Always thinking about food even on a full stomach? It's called Food Noise: a biological signal, not a lack of willpower. Here's why it happens and how to turn it off.
Scientific articles on the mechanism of action and developments of GLP-1 agonist peptides.
Always thinking about food even on a full stomach? It's called Food Noise: a biological signal, not a lack of willpower. Here's why it happens and how to turn it off.
Retatrutide is a novel triple GIP/GLP-1/glucagon receptor agonist. Learn about its mechanism of action, clinical trial results, and weight loss potential.
Mounjaro acts on 2 receptors (GLP-1 + GIP) with -22.5% weight loss in SURMOUNT trials. How it works, results, comparison with 1st and 3rd generation.
Ozempic works on 1 receptor (GLP-1), with -14.9% weight loss. Complete guide: how it works, limitations, adaptation signals, and 3rd-generation alternatives.
Retatrutide acts on 3 metabolic receptors. -28.7% weight in a trial on 5,800 people. Complete guide to the GLP-1/GIP/Glucagon triple agonist 2026.
Complete FAQ on weight loss peptides: safety, legality in Europe, costs, real results, common fears. Answers based on published clinical trials.
A comprehensive guide to GLP-1 receptor agonist mechanisms: from the incretin effect to appetite suppression and delayed gastric emptying.
Detailed analysis of retatrutide clinical data: from the Phase 2 NEJM study to Eli Lilly's Phase 3 TRIUMPH program.
Understanding the incretin system: how GIP, GLP-1, and glucagon regulate metabolism, appetite, and body weight. The scientific basis for modern weight-loss peptides.
Comprehensive analysis of documented GLP-1 receptor agonist side effects: nausea, gastrointestinal effects, long-term safety data, and management strategies.